• No results found

4   MATERIALS & METHODS 87

4.8   Protein expression and purification 96

4.8.1 Protein  expression  in  E.  coli  

Colonies   of   freshly   transformed   BL21   Star   (DE3)   cells   were   used   to   inoculate   20  ml   of   LB   supplemented   with   the   respective   antibiotics.   After   cultivation   for   4  h  at  37  °C,  3  l  of  prewarmed  LB  supplemented  with  the  respective  antibiotics   (and   with   2  g/l   glucose,   in   case   of   maltose-­‐binding   protein   (MBP)-­‐fusion   proteins)  were  inoculated  with  the  preculture.  At  an  OD600  of  ca.  0.3,  the  culture   was   cooled   to   18  °C   over   30-­‐60  min.   At   an   OD600   of   ca.   0.6,   expression   of   the   recombinant   protein   was   induced   by   adding   0.25  mM   Isopropyl-­‐β-­‐D-­‐

thiogalactopyranosid   (IPTG).   The   cells   were   cultured   at   18  °C   and   140  rpm   for   ca.  15-­‐17  h.  Afterwards,  cells  were  pelleted  (4400  x  g,  15  min,  4°C),  resuspended   in  the  respective  buffer,  and  either  flash  frozen  with  liquid  nitrogen  and  stored  at   -­‐80  °C  or  directly  used  for  purification.  

The   expression   of   Myo4p   (978-­‐1471)   was   improved   by   using   2x   TY   medium   supplemented   with   100   µg/ml   ampicillin.   In   addition,   2%   (v/v)   ethanol   was   added  just  before  induction.    

 

4.8.2 Protein  expression  in  insect  cells  

Recombinant  baculovirus  was  prepared  essentially  as  described  for  the  Bac-­‐to-­‐ Bac   system   (Invitrogen).   In   brief,   2  ml   SF21   cells   with   a   density   of   0.4  x  106  cells/ml   were   transfected   with   1-­‐2  µg   bacmid   DNA   using   the   FuGENE   HD   transfection   reagent   (Roche).   After   cultivation   for   at   least   four   days   at   27.5  °C,  the  supernatant  (P0)  of  two  transfections  (4  ml)  was  used  to  infect  10  ml   SF21  cells  with  a  density  of  1.4  x  106  cells/ml.  After  cultivation  for  four  days  at   27.5  °C  and  95  rpm,  the  cells  were  centrifuged  at  2000  x  g,  the  supernatant  (P1)  

was   sterile   filtered,   and   2  ml   thereof   were   used   to   infect   500  ml   SF21   with   a   density  of  0.4  x  106  cells/ml.  After  cultivation  for  four  days,  cells  were  pelleted,   the  supernatant  (P2)  was  sterile  filtered  and  stored  at  4  °C.  

A   culture   of   500  ml   High   Five   cells   with   a   density   of   1  x  106  cells/ml   were   infected   with   10-­‐30  ml   P2   virus   supernatant   and   cultivated   for   60-­‐70  h   at   27.5  °C.  Afterwards,  the  cells  were  collected  by  centrifugation  (2000  x  g,  15  min,   4  °C),   resuspended   in   the   respective   buffer,   and   either   flash   frozen   with   liquid   nitrogen  and  stored  at  -­‐80  °C  or  directly  used  for  purification.  

 

4.8.3 Purification  of  She2p,  She3p  (1-­234),  and  Myo4p  (978-­1471)  

Wild-­‐type  and  mutant  She2p  was  purified  essentially  as  described  (Müller  2009),   except  that  the  glutathione  S-­‐transferase  (GST)-­‐tag  was  cleaved  on  the  column.   Purification  of  His-­‐tagged  She3p  (1-­‐234)  and  Myo4p  (978-­‐1471)  was  performed   as  previously  described  (Heuck  2009).  

 

4.8.4 Purification  of  full-­length  She3p  constructs  

All   steps   were   carried   out   at   4  °C.   The   cell   pellet   of   a   0.5-­‐1  l   culture   was   resuspended   in   S3-­‐Ni-­‐A1   buffer   to   a   total   volume   of   ca.   40  ml.   One   tablet   of   ethylenediaminetetraacetic  acid  (EDTA)-­‐free  protease  inhibitor  cocktail  (Roche)   and   0.4  mM   phenylmethylsulfonyl   fluoride   (PMSF)   was   added.   The   cell   suspension  was  lysed  by  sonication  (3x  2  min,  amplitude:  35%,  output:  6).  The   lysate   was   cleared   by   centrifugation   (39000  x  g,   2x   20  min),   filtered   with   a   2.7  µM  filter  and  loaded  on  a  HisTrap  nickel  sepharose  column  (GE  Healthcare).   The  column  was  washed  successively  with  S3-­‐Ni-­‐A1  buffer,  S3-­‐Ni-­‐A2  buffer,  and   S3-­‐Hep-­‐A   buffer.   Protein   was   eluted   directly   on   a   HiTrap   Q   sepharose   column   attached  to  a  HiTrap  heparin  sepharose  column  (both:  GE  Healthcare)  with  60%   S3-­‐Ni-­‐B   and   40%   S3-­‐Hep-­‐A   buffer.   The   heparin   column   was   washed   with   S3-­‐Hep-­‐A  buffer,  15%  S3-­‐Hep-­‐B  buffer,  and  bound  protein  was  eluted  with  35%   S3-­‐Hep-­‐B  buffer.  The  protein  was  concentrated  by  ultrafiltration  with  an  Amicon  

Ultra  centrifugal  filter  (Millipore)  and  finally  purified  with  a  Superose  6  10/300   GL   column   (GE   Healthcare)   in   S3-­‐SEC   buffer.   Purified   She3p   was   usually   concentrated   to   8-­‐12  mg/ml   by   ultrafiltration.   Aliquots   were   flash   frozen   in   liquid  nitrogen  and  stored  at  -­‐80  °C.  SDS-­‐PAGE  and  UV-­‐spectroscopy  were  used   to  analyze  the  quality  of  the  purification.  The  ratio  of  absorbance  at  260  nm  and   280  nm   was   below   0.6   indicating   that   no   contaminating   nucleic   acids   were   present.  

S3-­‐Ni-­‐A1  buffer:     20  mM  HEPES/NaOH  (pH  7.8),  500  mM  NaCl,  20  mM  Imidazole   S3-­‐Ni-­‐A2  buffer:       20  mM  HEPES/NaOH  (pH  7.8),  1  M  NaCl,  40  mM  Imidazole   S3-­‐Ni-­‐B  buffer:       20  mM  HEPES/NaOH  (pH  7.8),  200  mM  NaCl,  500  mM  Imidazole   S3-­‐Hep-­‐A  buffer:     20  mM  HEPES/NaOH  (pH  7.8),  200  mM  NaCl  

S3-­‐Hep-­‐B  buffer:     20  mM  HEPES/NaOH  (pH  7.8),  1  M  NaCl,  2  mM  EDTA,  2  mM  DTT   S3-­‐SEC  buffer:       20  mM  HEPES/NaOH  (pH  7.8),  500  mM  NaCl,  2  mM  DTT  

 

4.8.5 Purification  of  C-­terminal  She3p  constructs  

C-­‐terminal  She3p  constructs  were  either  purified  via  an  N-­‐terminal  GST-­‐  or  MBP-­‐ tag.  In  addition,  a  C-­‐terminal  6x  His-­‐tag  was  present.  All  steps  were  carried  out  at   4  °C.  The  cell  pellet  was  resuspended  in  S3C-­‐GST-­‐A1  buffer  supplemented  with   EDTA-­‐free   protease   inhibitor   cocktail.   The   cell   suspension   was   lysed   by   sonication   (3x   4  min,   amplitude:   35%,   output:   6),   the   lysate   was   cleared   by   centrifugation   (30000  x  g,   30  min),   and   loaded   on   a   GSTrap   glutathione   sepharose   column   (GE   Healthcare).   The   column   was   washed   successively   with   S3C-­‐GST-­‐A1   buffer,   S3C-­‐GST-­‐A2   buffer,   and   again   with   S3C-­‐GST-­‐A1   buffer.   A   volume   of   5  ml   S3C-­‐GST-­‐A1   buffer   supplemented   with   100  µg   PreScission   protease  (GE  Healthcare)  was  applied  to  the  column.  After  incubation  at  4  °C  for   at  least  three  hours,  the  cleaved  protein  was  eluted  directly  on  a  HisTrap  nickel   sepharose   column   (GE   Healthcare)   with   S3C-­‐Ni-­‐A   buffer.   The   column   was   washed   with   15%   S3C-­‐Ni-­‐B   buffer.   Bound   protein   was   eluted   with   S3C-­‐Ni-­‐B   buffer,  concentrated  by  ultrafiltration,  and  separated  on  a  Superose  12  10/300   GL   column   (GE   Healthcare)   in   S3C-­‐SEC   buffer.   Pure   fractions   were   pooled   and   concentrated  by  ultrafiltration.  Since  the  She3p  C-­‐terminus  shows  no  absorption   at   280  nm,   the   concentration   was   estimated   from   sodium   dodecyl   sulfate  

polyacrylamide   gel   electrophoresis   (SDS-­‐PAGE)   with   Coomassie   blue   staining.   Aliquots  were  flash  frozen  with  liquid  nitrogen  and  stored  at  -­‐80  °C.  

In   the   case   of   MBP-­‐tagged   She3p   variants,   the   cell   pellet   was   resuspended   in   S3C-­‐MBP-­‐A   buffer   supplemented   with   5  mM   EDTA   and   protease   inhibitor   cocktail.  The  lysate  was  loaded  on  a  gravity  flow  column  filled  with  amylose  resin   (New  England  Biolabs).  The  column  was  washed  with  S3C-­‐MBP-­‐A  buffer,  bound   protein   was   eluted   with   S3C-­‐MBP-­‐B   buffer,   and   loaded   on   a   HisTrap   nickel   sepharose  column  (GE  Healthcare).  The  following  steps  of  the  purification  were   performed  as  described  above.  

S3C-­‐GST-­‐A1  buffer:     20  mM  HEPES/NaOH  (pH  7.8),  500  mM  NaCl   S3C-­‐GST-­‐A2  buffer:     20  mM  HEPES/NaOH  (pH  7.8),  1  M  NaCl   S3C-­‐MBP-­‐A  buffer:     20  mM  HEPES/NaOH  (pH  7.8),  200  mM  NaCl  

S3C-­‐MBP-­‐B  buffer:     20  mM  HEPES/NaOH  (pH  7.8),  200  mM  NaCl,  10  mM  Maltose   S3C-­‐Ni-­‐A  buffer:       20  mM  HEPES/NaOH  (pH  7.8),  500  mM  NaCl,  20  mM  Imidazole   S3C-­‐Ni-­‐B  buffer:       20  mM  HEPES/NaOH  (pH  7.8),  500  mM  NaCl,  500  mM  Imidazole   S3C-­‐SEC  buffer:     20  mM  HEPES/NaOH  (pH  7.8),  200  mM  NaCl  

 

4.8.6 Purification  of  full-­length  Myo4p  

All   steps   were   carried   out   at   4  °C.   The   cell   pellet   of   a   0.5-­‐1  l   culture   was   resuspended   in   M4-­‐HB   buffer   to   a   total   volume   of   ca.   40  ml   and   lysed   by   sonication   (3x   2  min,   amplitude:   35%,   output:   6).   The   lysate   was   cleared   by   centrifugation   (39000  x  g,   2x   20  min),   filtered   with   a   2.7  µM   filter,   and   1  ml   ANTI-­‐FLAG  M2  affinity  gel  (Sigma-­‐Aldrich)  was  added.  The  mixture  was  gently   agitated   for   60  min,   transferred   into   a   gravity   flow   column   and   washed   with   M4-­‐FLAG-­‐A   buffer.   Bound   protein   was   eluted   five   times   with   1  ml   M4-­‐FLAG-­‐B   buffer.  The  eluate  was  dialyzed  two  times  against  1.5  l  of  ATPase  buffer,  followed   by   dialysis   against   0.5  l   ATPase   buffer   supplemented   with   50%   (v/v)   glycerol.   The  protein  was  stored  at  -­‐20  °C.  The  concentration  of  the  protein  was  estimated   by  comparing  the  intensity  of  the  Coomassie  blue  staining  of  Myo4p  with  known   concentrations  of  bovine  serum  albumin  (BSA)  in  an  SDS-­‐polyacrylmide  gel.  

M4-­‐HB  buffer:     20  mM  Imidazole  (pH  7.5),  200  mM  NaCl,  5  mM  MgCl2,  1  mM  EDTA,   1  mM  EGTA,  7%  (w/v)  Sucrose,  1  mM  PMSF,  3  mM  ATP,    

1  tablet  EDTA-­‐free  protease  inhibitor  cocktail  per  50  ml  buffer   M4-­‐FLAG-­‐A  buffer:     20  mM  Imidazole  (pH  7.5),  150  mM  KCl,  5  mM  MgCl2,  1  mM  EDTA,    

1  mM  EGTA,  0.5  mM  PMSF,  3  mM  ATP,    

1  tablet  EDTA-­‐free  protease  inhibitor  cocktail  per  50  ml  buffer   M4-­‐FLAG-­‐B  buffer:     20  mM  Imidazole  (pH  7.5),  150  mM  KCl,  5  mM  MgCl2,  1  mM  EDTA,    

1  mM  EGTA,  0.5  mM  PMSF,  0.1  mg/ml  FLAG  peptide,  

1  tablet  EDTA-­‐free  protease  inhibitor  cocktail  per  50  ml  buffer   ATPase  buffer:     20  mM  HEPES/NaOH  (pH  7.8),  100  mM  NaCl,  25  mM  KCl,  2  mM  MgCl2,  

1  mM  EGTA,  2  mM  DTT  

 

4.8.7 Purification  of  actin  from  rabbit  muscle  

Actin   was   purified   from   5  g   rabbit   muscle   acetone   powder   (Sigma-­‐Aldrich,   M6890).   All   steps   were   carried   out   at   4  °C.   The   frozen   acetone   powder   was   crushed   into   small   pieces   and   actin   was   extracted   6-­‐8   times.   Therefore,   the   powder   was   covered   with   G-­‐buffer,   stirred   for   20-­‐30  min,   and   filtered   with   a   compress.   The   first   filtrate   was   discarded.   All   other   filtrates   were   pooled   and   cleared   by   ultracentrifugation   (Type   45   Ti   rotor,   41  krpm,   30  min).   The   supernatant  was  supplemented  with  800  mM  KCl,  2  mM  MgCl2,  and  1  mM  ATP,   the   pH   was   adjusted   to   8,   and   polymerization   of   actin   was   allowed   to   proceed   over  night  under  slow  stirring.  F-­‐actin  was  pelleted  by  ultracentrifugation  (Type   45   Ti   rotor,   41  krpm,   3  h).   The   pellets   were   washed   with   G-­‐buffer   and   resuspended  in  3-­‐5  ml  of  G-­‐buffer  with  a  dounce  homogenizer.  The  solution  was   dialyzed  two  times  against  2  l  of  G-­‐buffer.  After  ultracentrifugation  (Type  70.1  Ti   rotor,   44  krpm,   2  h)   the   supernatant   contained   the   finally   purified   G-­‐actin.   The   concentration   was   determined   by   absorption   at   290  nm   using   an   extinction   coefficient  of  26000  M-­‐1cm-­‐1  (Abs  0.1%  =  0.62).  G-­‐actin  could  be  stored  for  up  to   two   weeks   at   4  °C   when   daily   dialyzed   against   G-­‐buffer   supplemented   with   0.02%  (w/v)  sodium  azide.  After  polymerization  (Section  4.11.15),  F-­‐actin  could   be  flash  frozen  in  liquid  nitrogen  and  stored  at  -­‐80  °C.  

G-­‐buffer:  2  mM  TRIS/HCl  (pH4°C  8),  0.2  mM  CaCl2,  0.2  mM  ATP,  0.5  mM  DTT